MedPath

Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery

Phase 3
Completed
Conditions
Thyroidectomy
Thyroid Diseases
Interventions
Other: NaCl 0.9%
Registration Number
NCT01189292
Lead Sponsor
Cantonal Hospital of St. Gallen
Brief Summary

The study is to compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
152
Inclusion Criteria
  • Age > 18
  • Planned partial or total thyroidectomy
Exclusion Criteria
  • History of adverse effects to dexamethasone or propyleneglycol or di-natrium-EDTA
  • Patients with chronic pain
  • Necessity for opioids-application in the postoperative course
  • Not possible administration of a cervical block (0.5% bupivacaine at a dose of 20ml)
  • Patients with Diabetes mellitus
  • Pregnancy (test in young women)
  • Glaucoma
  • Patients who received antiemetic therapy within 48h before surgery
  • Patients with acute pain requiring painkillers others than paracetamol or more than single dose NSAR treatment within 48h before surgery
  • Use of psychotropic drugs
  • Incompliant patients
  • Preoperatively high suspicion of malignancy
  • Re-operations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo (NaCl 0.9%)NaCl 0.9%-
Dexamethasone injectionDexamethasoneAdministration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Primary Outcome Measures
NameTimeMethod
Incidence of Postoperative Nausea and Vomitingwithin 48 hours after surgery

Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)

* any PONV event within 48 hours after surgery

* PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery

Secondary Outcome Measures
NameTimeMethod
Degree of Post Operative Nausea and Vomiting8 hours after surgery

mild nausea:......single administration of an antiemetic drug

severe nausea: repeated administration of antiemetic drugs

vomiting:...........at least one vomiting event

Postoperative Pain After Physical Stress4 and 8 hours after surgery

Compare grade of pain between the treatment (dexamethasone) and the control (saline) group

* Pain was measured using a verbal rating scale ranging from 0 (no pain) to 10 in steps of 1

* before obtaining the pain rating, patients were asked to turn their heads (physical stress)

Necessary Anesthesiological Medicationmeasured from beginning of anaesthesia to end of anaesthesia

Compare the amount of necessary anesthesiologic medication during the operation between the treatment (dexamethasone) and the control (saline) group

Incidence of Postoperative Nausea and Vomitingwithin 48 hours after surgery (PP)

Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)

* any PONV event within 48 hours after surgery

* PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery

Length of Hospital StayDifference between day of admission and day of discharge

Compare the lengths of hospital stay between the treatment (dexamethasone) and the control (saline) group

Trial Locations

Locations (1)

Department of Surgery

🇨🇭

St. Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath